Alerts will be sent to your verified email
Verify Email
KOPRAN
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Kopran Limited is a pharmaceutical company that manufactures Active Pharmaceutical Ingredients and Finished Dosage Forms, with a wide range of products for international markets. It also offers specialty products and operates subsidiaries in research and life sciences.
Kopran major competitors are Shree Ganesh Remed., NGL Fine-Chem, Themis Medicare, Everest Organics, Haleos Labs, Nectar Lifesciences, Bajaj Healthcare.
Market Cap of Kopran is ₹767 Crs.
While the median market cap of its peers are ₹757 Crs.
Kopran seems to be less financially stable compared to its competitors.
Altman Z score of Kopran is 3.45 and is ranked 4 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Mar | Dec | ||||||||||||||||
| Investor Presentation | May Jul | Mar Jun Sep Dec | Sep Dec | Mar May | Mar Sep | Sep Dec | ||||||||||||
| Conference Call | Mar | Mar Jun Sep Dec | Sep Dec | |||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
